Trendlines Invests in Celleste Bio to Make Our Chocolate Supply Sustainable

Stock Information for NervGen Pharma Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NervGen Pharma Corp.

Arcuro Medical Appoints Jamal Rushdy CEO
Vessi Medical Closes $16.5 Million Series A Round for Innovative Cryotherapy Bladder Cancer Treatment
OTC Markets Group Announces the 2024 OTCQX Best 50
Omeq Medical Receives FDA Regulatory Clearance for its Smart Device for Epidural Injections
liberDi Receives FDA Regulatory Clearance for its Digital Dialysis System
Collaborative Study by NeuroQuest and AIBL Shows Specific Biomarkers for Alzheimer's Could Lead to Blood-based Screening Tool
Biotech Food Colorant Startup Phytolon Closes $14.5 Million Series A Funding Round, Led by DSM Venturing
Bayer Trendlines Ag Innovation Fund Co-invests with Trendlines in TierraSpec

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.